AstraZeneca

Lilly
Pharma

Lilly ups oral SERD battle with Inluriyo, Verzenio combo nod

Lilly’s Inluriyo-Verzenio regimen could challenge AstraZeneca’s argument for its novel first-line switch approach with an oral SERD.
Angus Liu Sep 18, 2026 3:30pm
European Union flags waving in front of the EU Parliament building in Brussels

Europe recommends Novo's Frehemgo and AZ's Klygefa

Sep 18, 2026 11:23am
football goalpost touchdown score

AZ, Daiichi's Enhertu nabs long-sought NHS blessing from NICE

Sep 16, 2026 7:30pm
Enhertu

Increased deaths shadow Enhertu’s first-line lung cancer data

Sep 13, 2026 7:00pm
AZ

AstraZeneca’s Etcamah flunks first-line breast cancer trial

Sep 12, 2026 12:43pm
AZ

FDA's surprise approval of AZ's oral SERD sets new paradigm

Sep 8, 2026 10:35am